NCT01174355View on ClinicalTrials.gov

A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Attention Deficit and Hyperactivity Disorder

Interventions

DRUG

ND0801

Confidential

Trial Locations (2)

Unknown

Rambam Hospital, Haifa

Shalvata Mental Health Center (SMHC), Hod HaSharon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NeuroDerm Ltd.

INDUSTRY

NCT01174355 - A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter